Will MRNA rotate? CVS, UNH, JNJ all rotating in q1 of 2025. Will MRNA start to roll over and complete the weekly harmonic pattern and go for the TYPE 1 cycle? Long hold but seems like a no brainer. 🥂
Bird Flu - Short Squeeze incoming?Strong downtrend, ABC correction with the final C wave possibly in. Potential for a short squeeze as Moderna receives funding to develop a Bird Flu vaccine for the ongoing outbreak.
The financials don’t look great, this would be a short term trade with a tight stop loss.
Not financial advice, ju
Bottom is behind us Moderna has gone through panic selling which tells me a generational bottom has probably formed.
$MRNA has 50-100% upside from $43 in FY 2025- NASDAQ:MRNA had one of the worst year in 2024. However, cash position is underestimated and the market cap has gotten very low for a company which has proven it's excellence in manufacturing drug and research.
- NASDAQ:MRNA is working on cancer prevention vaccines which might get approvals
$MRNA to $90-115 | 100-150% upside in FY 2025- NASDAQ:MRNA most of the people are familiar with the vaccine stocks from pandemic fiasco.
- This company is beaten down to the ground and has low market cap as compared to other biopharma stocks.
- 2025 would be easier for merger and acquisition which will be good for moderna as it might get a
Moderna Bullish Outlook With a broken Resistance , an oversold RSI and a beautiful oversold MFI , we anticipate MRNA to rise to the top of the descending and potential top of bull flag formation at $125.00 in the near term
- 160% ROI from $48.00 to $125.00
$MRNA long, oversold, AI cancer momentumIncreasing volume, oversold at support, NYSE:ORCL 500B Stargate publicity
MRNA - short term profit targets $46 - $49MRNA - short term profit targets $46 - $49
17K call options at strike $41.5 expiring 31 Jan
17K PuT options at strike $40 expiring 21 Mar
Moderna (MRNA) Down 92% from All-Time High – What's Next?Overview:
Moderna (MRNA) has fallen sharply, trading 92% below its all-time high of $497.49 (reached in 2021). With this massive decline, investors might wonder: Is the stock poised for a recovery or headed lower?
Key Insights:
Support Levels:
Current price hovers near the 2020 pre-pandemic breako
The Share Price of Moderna (MRNA) Surged Over 10% in a DayThe Share Price of Moderna (MRNA) Surged Over 10% in a Day
As shown by the chart of pharmaceutical company Moderna (MRNA):
→ 2024 was an extremely difficult year, with the price falling by approximately 60%;
→ however, in early 2025, we can see signs of renewed strength.
During yesterday’s sessio
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where MRNA is featured.
